Center-Authored Papers

Filters: Author is Gralow, Julie  [Clear All Filters]
Journal Article
Reece JC, Chan Y-F, Herbert J, Gralow J, Fann JR.  2013.  Course of depression, mental health service utilization and treatment preferences in women receiving chemotherapy for breast cancer.. General hospital psychiatry. Abstract
Lichtman SM, Cirrincione CT, Hurria A, Jatoi A, Theodoulou M, Wolff AC, Gralow J, Morganstern DE, Magrinat G, Cohen HJ et al..  2016.  Effect of Pretreatment Renal Function on Treatment and Clinical Outcomes in the Adjuvant Treatment of Older Women With Breast Cancer: Alliance A171201, an Ancillary Study of CALGB/CTSU 49907.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. Abstract
Goss PE, Ingle JN, Pritchard KI, Robert NJ, Muss H, Gralow J, Gelmon K, Whelan T, Strasser-Weippl K, Rubin S et al..  2016.  Extending Aromatase-Inhibitor Adjuvant Therapy to 10 Years.. The New England journal of medicine. Abstract
Hertz DL, Barlow WE, Kidwell KM, Albain KS, Vandenberg TA, Dakhil SR, Tirumali NR, Livingston RB, Gralow J, Hayes DF et al..  2016.  Fulvestrant decreases anastrozole drug concentrations when taken concurrently by patients with metastatic breast cancer treated on SWOG study S0226.. British journal of clinical pharmacology. Abstract
Ginsburg O, Bray F, Coleman MP, Vanderpuye V, Eniu A, Kotha RS, Sarker M, Huong TT, Allemani C, Dvaladze A et al..  2016.  The global burden of women's cancers: a grand challenge in global health.. Lancet (London, England). Abstract
Moore HCF, Unger JM, Phillips K-A, Boyle F, Hitre E, Porter D, Francis PA, Goldstein LJ, Gomez HL, Vallejos CS et al..  2015.  Goserelin for ovarian protection during breast-cancer adjuvant chemotherapy.. The New England journal of medicine. 372(10):923-32. Abstract
Chang H-Y, Jotwani AC, Lai Y-H, Jensen MP, Syrjala KL, Fann JR, Gralow J.  2016.  Hot flashes in breast cancer survivors: Frequency, severity and impact.. Breast (Edinburgh, Scotland). 27:116-121. Abstract
Dueck AC, Reinholz MM, Geiger XJ, Tenner K, Ballman K, Jenkins RB, Riehle D, Chen B, McCullough AE, Davidson NE et al..  2013.  Impact of c-MYC Protein Expression on Outcome of Patients with Early-Stage HER2+ Breast Cancer Treated with Adjuvant Trastuzumab NCCTG (Alliance) N9831.. Clinical cancer research : an official journal of the American Association for Cancer Research. 19(20):5798-807. Abstract
Sonnenblick A, Agbor-Tarh D, Bradbury I, Di Cosimo S, Azim HA, Fumagalli D, Sarp S, Wolff AC, Andersson M, Kroep J et al..  2017.  Impact of Diabetes, Insulin, and Metformin Use on the Outcome of Patients With Human Epidermal Growth Factor Receptor 2-Positive Primary Breast Cancer: Analysis From the ALTTO Phase III Randomized Trial.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. :JCO2016697722. Abstract
Knaul FM, Bhadelia A, Gralow J, Arreola-Ornelas H, Langer A, Frenk J.  2012.  Meeting the emerging challenge of breast and cervical cancer in low- and middle-income countries.. International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics. 119 Suppl 1:S85-8. Abstract
Dunnwald L, Doot R, Gralow J, Ellis G, Livingston R, Linden H, Specht J, Gadi V, Kurland B, Mankoff D.  2009.  PET tumor metabolism in locally advanced breast cancer patients: Predicting outcome after neoadjuvant chemotherapy by kinetic analysis of FDG PET. Society of Nuclear Medicine Annual Meeting Abstracts. 50:24.
Hershman DL, Unger JM, Crew KD, Awad D, Dakhil SR, Gralow J, Greenlee H, Lew DL, Minasian LM, Till C et al..  2015.  Randomized Multicenter Placebo-Controlled Trial of Omega-3 Fatty Acids for the Control of Aromatase Inhibitor-Induced Musculoskeletal Pain: SWOG S0927.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. Abstract
Lehman CD, Lee JM, DeMartini WB, Hippe DS, Rendi MH, Kalish G, Porter P, Gralow J, Partridge SC.  2016.  Screening MRI in Women With a Personal History of Breast Cancer.. Journal of the National Cancer Institute. 108(3) Abstract
Jatoi A, Muss H, Allred JB, Cohen HJ, Ballman K, Hopkins JO, Gajra A, Lafky J, Wolff A, Kottschade L et al..  2016.  Social support and its implications in older, early-stage breast cancer patients in CALGB 49907 (Alliance A171301).. Psycho-oncology. 25(4):441-446. Abstract
Moreno-Aspitia A, Hillman DW, Dyar SH, Tenner KS, Gralow J, Kaufman PA, Davidson NE, Lafky JM, Reinholz MM, Lingle WL et al..  2013.  Soluble human epidermal growth factor receptor 2 (HER2) levels in patients with HER2-positive breast cancer receiving chemotherapy with or without trastuzumab: Results from North Central Cancer Treatment Group adjuvant trial N9831.. Cancer. Abstract
Wang H, Yumul R, Cao H, Ran L, Fan X, Richter M, Epstein F, Gralow J, Zubieta C, Fender P et al..  2013.  Structural and functional studies on the interaction of adenovirus fiber knobs and desmoglein 2.. Journal of virology. 87(21):11346-62. Abstract
Carlson JJ, Thariani R, Roth J, Gralow J, Henry LN, Esmail L, Deverka P, Ramsey SD, Baker L, Veenstra DL.  2013.  Value-of-Information Analysis within a Stakeholder-Driven Research Prioritization Process in a US Setting: An Application in Cancer Genomics.. Medical decision making : an international journal of the Society for Medical Decision Making. 33(4):463-71. Abstract